Who owns Charles River Laboratories (CRL)?
310 US mutual funds and ETFs from 148 fund families reported a position in CRL for the quarter ending 2026-06-30. Against their own report a quarter earlier, 79 raised shares, 17 opened a new position, 124 cut and 22 sold out.
Largest fund families
| Fund family | Funds | Share of fund-held shares |
|---|---|---|
| Vanguard Index Funds | 4 | 25.9% |
| Fidelity Contrafund | 2 | 12.4% |
| Harris Associates Investment Trust | 2 | 9.8% |
| Ishares Trust | 15 | 9.4% |
| Allspring Funds Trust | 4 | 8.5% |
| Ariel Investment Trust | 2 | 4.1% |
Tracked managers holding CRL
| Investor | Book weight |
|---|---|
| Ariel | 3.4% |
Source: SEC Form N-PORT, which funds file about 60 days after quarter end, and the latest 13F filings. Share counts, not trades: a change can reflect fund inflows or outflows rather than a decision about CRL. A record of holdings, not a forecast and not investment advice. See all owner pages or the forecast board for the names our model ranks.
Our model ranks every tracked manager’s likely next buys from 13F filings. Request the dataset sample with a work email.
The predicted next buys, fresh disclosures, and the week’s catalysts. One email a week. Honest numbers, never advice.